We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Dual Signals from Gene Promote Breast Cancer Growth

By Biotechdaily staff writers
Posted on 17 Oct 2002
Researchers studying how cancer cells spread within the hollow spaces or lumen of the human breast have found that two separate genetic signals are required to prevent cell death and allow proliferation, and that the common breast cancer gene, HER2 (also called ErbB2), is able to provide both signals. More...
Their findings were published in the October 4, 2002, issue of Cell.

The investigators, from Harvard Medical School (Boston, MA, USA), utilized an in vitro three-dimensional epithelial cell culture model to analyze the role of apoptosis in the formation and maintenance of a hollow glandular architecture.

They found that neither inhibiting apoptosis (by exogenously expressing antiapoptotic Bcl family proteins) nor enhancing proliferation (via Cyclin D1 or HPV E7 overexpression) caused luminal filling, suggesting that the glandular architecture was able to resist such isolated oncogenic insults. However, the lumen became filled when oncogenes that enhance proliferation were co-expressed with those that inhibit apoptosis, or when ErbB2, which induces both activities, was activated by homodimerization.

These studies showed that during the early development of breast cancer, tumor cells must not only proliferate but also overcome the normal cell death mechanisms that maintain the glandular architecture.



Related Links:
Harvard

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.